Immunohistochemical Differentiation between Reactive and Malignant Mesothelial Proliferations in Pleural Effusion

Diagnostic utility of BRCA1-associated protein 1 (BAP1), Programmed Cell Death4 (PCD4) and Epithelial membrane antigen (EMA) expression in differentiation of malignant mesotheliom

Histopathological and Immunohistochemical Study of D2-40 Expression in Malignant Pleural Mesothelioma and Metastatic Adenocarcinoma

Significance of MUC4 in epithelioid mesothelioma of the pleura, adenocarcinoma & squamous cell carcinoma of the lung (Immunohistochemical Study)

Comparative study of BAP1 and CD147 expression in the diagnosis of malignant mesothelioma

Clinicopathological Impact of CPA4, UHRF1, Glypican-1, and CD90 Expression in Lung Adenocarcinoma and Epithelioid Malignant Mesothelioma

Review Article: D2-40 Expression in Malignant Pleural Mesothelioma (Epithelioid Type)

The Significance of BRCA-associated Protein (BAP1) and Calretinin Expression in Malignant Pleural Mesothelioma and Non-small Cell Lung Carcinoma: An Immunohistochemical Study

Value of E-cadherin and desmin immunocytochemistry in distinguishing metastatic adenocarcinoma from reactive mesothelial cells in serous effusions

EMMPIRRIN (CD147) and matrix metalloproteinase-9 (MMP9) immunohistochemical expression in breast carcinoma: Relationship with clinicopathological paremeters